258 related articles for article (PubMed ID: 33947294)
1. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004):
Mishra CB; Mongre RK; Prakash A; Jeon R; Supuran CT; Lee MS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):954-963. PubMed ID: 33947294
[TBL] [Abstract][Full Text] [Related]
2. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
3. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors.
Yamali C; Gul HI; Ece A; Bua S; Angeli A; Sakagami H; Sahin E; Supuran CT
Bioorg Chem; 2019 Nov; 92():103222. PubMed ID: 31499260
[TBL] [Abstract][Full Text] [Related]
5. Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX.
Dvořanová J; Kugler M; Holub J; Šícha V; Das V; Nekvinda J; El Anwar S; Havránek M; Pospíšilová K; Fábry M; Král V; Medvedíková M; Matějková S; Lišková B; Gurská S; Džubák P; Brynda J; Hajdúch M; Grüner B; Řezáčová P
Eur J Med Chem; 2020 Aug; 200():112460. PubMed ID: 32505851
[TBL] [Abstract][Full Text] [Related]
6. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
8. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
9. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
10. A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity.
Su X; Wang WJ; Cao Q; Zhang H; Liu B; Ling Y; Zhou X; Mao ZW
Angew Chem Int Ed Engl; 2022 Feb; 61(8):e202115800. PubMed ID: 34842317
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
Koyuncu I; Tülüce Y; Slahaddin Qadir H; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):703-711. PubMed ID: 30810431
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
[TBL] [Abstract][Full Text] [Related]
13. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms.
Sharonova T; Paramonova P; Kalinin S; Bunev A; Gasanov RЕ; Nocentini A; Sharoyko V; Tennikova TB; Dar'in D; Supuran CT; Krasavin M
Eur J Med Chem; 2021 Jun; 218():113352. PubMed ID: 33774343
[TBL] [Abstract][Full Text] [Related]
14. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity.
Angeli A; Trallori E; Ferraroni M; Di Cesare Mannelli L; Ghelardini C; Supuran CT
Eur J Med Chem; 2018 Sep; 157():1214-1222. PubMed ID: 30193219
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel tellurides bearing benzensulfonamide moiety as carbonic anhydrase inhibitors with antitumor activity.
Tanini D; Ricci L; Capperucci A; Di Cesare Mannelli L; Ghelardini C; Peat TS; Carta F; Angeli A; Supuran CT
Eur J Med Chem; 2019 Nov; 181():111586. PubMed ID: 31401537
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
18. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX.
Mondal UK; Doroba K; Shabana AM; Adelberg R; Alam MR; Supuran CT; Ilies MA
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498779
[TBL] [Abstract][Full Text] [Related]
19. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors.
Gul HI; Yamali C; Sakagami H; Angeli A; Leitans J; Kazaks A; Tars K; Ozgun DO; Supuran CT
Bioorg Chem; 2018 Apr; 77():411-419. PubMed ID: 29427856
[TBL] [Abstract][Full Text] [Related]
20. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
Krasavin M; Shetnev A; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Korsakov M; Tennikova TB; Supuran CT
Eur J Med Chem; 2019 Apr; 168():301-314. PubMed ID: 30826507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
